Cargando…
Trial of Zolpidem, Eszopiclone, and Other GABA Agonists in a Patient with Progressive Supranuclear Palsy
Progressive supranuclear palsy (PSP) is a progressive, debilitating neurodegenerative disease of the Parkinson-plus family of syndromes. Unfortunately, there are no pharmacologic treatments for this condition, as most sufferers of the classic variant respond poorly to Parkinson medications such as l...
Autores principales: | Chang, Andrew Young, Weirich, Erica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209775/ https://www.ncbi.nlm.nih.gov/pubmed/25371679 http://dx.doi.org/10.1155/2014/107064 |
Ejemplares similares
-
Zolpidem in Progressive Supranuclear Palsy
por: Dash, Sandip K.
Publicado: (2013) -
The impact of age on the hypnotic effects of eszopiclone and zolpidem in the guinea pig
por: Xi, Mingchu, et al.
Publicado: (2009) -
Eszopiclone and Zolpidem Produce Opposite Effects on Hippocampal Ripple Density
por: Becker, Logan A., et al.
Publicado: (2022) -
Progressive Supranuclear Palsy: The Other Side of the Fence
por: Sofaer-Bennett, Beatrice
Publicado: (2021) -
The Z-Drugs Zolpidem, Zaleplon, and Eszopiclone Have Varying Actions on Human GABA(A) Receptors Containing γ1, γ2, and γ3 Subunits
por: Richter, Grant, et al.
Publicado: (2020)